tiprankstipranks
Avacta Group Appoints New Chairman, Eyes Growth
Company Announcements

Avacta Group Appoints New Chairman, Eyes Growth

Avacta Group plc (GB:AVCT) has released an update.

Don't Miss Our Christmas Offers:

Avacta Group plc, a life sciences company focusing on cancer treatments and diagnostics, has appointed Shaun Chilton as the new Non-Executive Chairman, succeeding Eliot Forster. Chilton, who has a notable history of leading pharmaceutical companies and driving business growth, aims to support Avacta’s clinical development of their proprietary pre|CISION™ platform. The company is transitioning towards a therapeutics-focused organization, with ongoing board evolution to bolster its strategic objectives.

For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAvacta Group Opens Phase 1b Trial for Targeted Cancer Therapy
TipRanks UK Auto-Generated NewsdeskAvacta Group Advances with Targeted Cancer Therapies
TipRanks UK Auto-Generated NewsdeskAvacta Group Unveils Promising Cancer Therapy Advances
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App